The good news is the 1st quarter is the last quarter that we won't show good growth. With about $1.2M in 2Q we will be growing about 50% over 2Q09 and 1Q10. And it will get better each quarter, especially if we close the Biocells deal.
Don't worry about the mule going blind just load the wagon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.